Sun Pharma Advanced Research Company Limited (SPARC) - Net Assets

Latest as of September 2025: Rs-3.45 Billion INR ≈ $-37.27 Million USD

Based on the latest financial reports, Sun Pharma Advanced Research Company Limited (SPARC) has net assets worth Rs-3.45 Billion INR (≈ $-37.27 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs3.22 Billion ≈ $34.87 Million USD) and total liabilities (Rs6.67 Billion ≈ $72.14 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Sun Pharma Advanced Research Company Lim liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs-3.45 Billion
% of Total Assets	-106.89%
Annual Growth Rate	N/A
5-Year Change	N/A
10-Year Change	-825.52%
Growth Volatility	536.98

Sun Pharma Advanced Research Company Limited - Net Assets Trend (2007–2025)

This chart illustrates how Sun Pharma Advanced Research Company Limited's net assets have evolved over time, based on quarterly financial data. Also explore Sun Pharma Advanced Research Company Lim total assets for the complete picture of this company's asset base.

Annual Net Assets for Sun Pharma Advanced Research Company Limited (2007–2025)

The table below shows the annual net assets of Sun Pharma Advanced Research Company Limited from 2007 to 2025. For live valuation and market cap data, see Sun Pharma Advanced Research Company Lim (SPARC) total market value.

Year	Net Assets	Change
2025-03-31	Rs-2.17 Billion ≈ $-23.46 Million	-272.52%
2024-03-31	Rs1.26 Billion ≈ $13.60 Million	-75.48%
2023-03-31	Rs5.13 Billion ≈ $55.45 Million	+1542.14%
2022-03-31	Rs312.26 Million ≈ $3.38 Million	+118.56%
2021-03-31	Rs-1.68 Billion ≈ $-18.20 Million	-802.72%
2020-03-31	Rs-186.38 Million ≈ $-2.02 Million	-106.29%
2019-03-31	Rs2.96 Billion ≈ $32.04 Million	+60.37%
2018-03-31	Rs1.85 Billion ≈ $19.98 Million	+15.71%
2017-03-31	Rs1.60 Billion ≈ $17.27 Million	+433.89%
2016-03-31	Rs299.03 Million ≈ $3.23 Million	-70.04%
2015-03-31	Rs997.99 Million ≈ $10.79 Million	-28.36%
2014-03-31	Rs1.39 Billion ≈ $15.06 Million	+28.47%
2013-03-31	Rs1.08 Billion ≈ $11.73 Million	+262.79%
2012-03-31	Rs-666.09 Million ≈ $-7.20 Million	-1284.47%
2011-03-31	Rs56.23 Million ≈ $608.16K	-60.19%
2010-03-31	Rs141.24 Million ≈ $1.53 Million	-60.41%
2009-03-31	Rs356.78 Million ≈ $3.86 Million	-20.39%
2008-03-31	Rs448.18 Million ≈ $4.85 Million	-9.82%
2007-03-31	Rs497.01 Million ≈ $5.37 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Sun Pharma Advanced Research Company Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 2316617400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2025)

Component	Amount	Percentage
Common Stock	Rs324.50 Million	%
Other Comprehensive Income	Rs340.45 Million	%
Other Components	Rs20.38 Billion	%
Total Equity	Rs-2.17 Billion	100.00%

Sun Pharma Advanced Research Company Limited Competitors by Market Cap

The table below lists competitors of Sun Pharma Advanced Research Company Limited ranked by their market capitalization.

Company	Market Cap
Zhejiang Jinsheng New Materials Co SHE:300849	$502.21 Million
NHN KCP Corp KQ:060250	$502.25 Million
Altice USA Inc NYSE:ATUS	$502.28 Million
Lungteh Shipbldg Co Ltd TW:6753	$502.34 Million
Bansal Wire Industries Ltd NSE:BANSALWIRE	$501.93 Million
Reservoir Media Inc NASDAQ:RSVR	$501.84 Million
Mill City Ventures III Ltd NASDAQ:MCVT	$501.70 Million
China Railway Prefabricated Construction Co Ltd SHE:300374	$501.63 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Sun Pharma Advanced Research Company Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 1,257,554,000 to -2,169,500,000, a change of -3,427,054,000 (-272.5%).
Net loss of 3,425,100,000 reduced equity.
Other comprehensive income increased equity by 615,000.
Other factors decreased equity by 2,569,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Rs-3.43 Billion	-157.88%
Other Comprehensive Income	Rs615.00K	+0.03%
Other Changes	Rs-2.57 Million	-0.12%
Total Change	Rs-	-272.52%

Book Value vs Market Value Analysis

This analysis compares Sun Pharma Advanced Research Company Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2007-03-31	Rs2.34	Rs143.04	x
2008-03-31	Rs2.11	Rs143.04	x
2009-03-31	Rs1.68	Rs143.04	x
2010-03-31	Rs0.67	Rs143.04	x
2011-03-31	Rs0.27	Rs143.04	x
2012-03-31	Rs-3.14	Rs143.04	x
2013-03-31	Rs4.94	Rs143.04	x
2014-03-31	Rs5.85	Rs143.04	x
2015-03-31	Rs4.22	Rs143.04	x
2016-03-31	Rs1.26	Rs143.04	x
2017-03-31	Rs6.49	Rs143.04	x
2018-03-31	Rs7.45	Rs143.04	x
2019-03-31	Rs11.59	Rs143.04	x
2020-03-31	Rs-0.71	Rs143.04	x
2021-03-31	Rs-6.42	Rs143.04	x
2022-03-31	Rs1.19	Rs143.04	x
2023-03-31	Rs18.01	Rs143.04	x
2024-03-31	Rs3.88	Rs143.04	x
2025-03-31	Rs-6.68	Rs143.04	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Sun Pharma Advanced Research Company Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.00%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -477.23%
• Asset Turnover: 0.21x
• Equity Multiplier: 0.00x
Recent ROE (0.00%) is above the historical average (-97.72%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2007	-10.03%	-1607.26%	0.01x	1.11x	Rs-99.54 Million
2008	-10.89%	-13.03%	0.61x	1.37x	Rs-93.65 Million
2009	-25.62%	-26.01%	0.57x	1.73x	Rs-127.08 Million
2010	-152.60%	-62.64%	0.48x	5.11x	Rs-229.66 Million
2011	-151.16%	-14.57%	0.75x	13.78x	Rs-90.63 Million
2012	0.00%	-249.28%	0.34x	0.00x	Rs-655.71 Million
2013	-20.75%	-25.77%	0.42x	1.93x	Rs-333.38 Million
2014	21.77%	18.15%	0.91x	1.32x	Rs163.94 Million
2015	-39.60%	-25.38%	1.09x	1.43x	Rs-495.00 Million
2016	-234.07%	-43.40%	0.99x	5.44x	Rs-729.82 Million
2017	-75.33%	-66.44%	0.66x	1.72x	Rs-1.36 Billion
2018	-106.64%	-251.73%	0.25x	1.67x	Rs-2.15 Billion
2019	-49.09%	-79.53%	0.46x	1.35x	Rs-1.75 Billion
2020	0.00%	-406.70%	0.28x	0.00x	Rs-3.11 Billion
2021	0.00%	-59.75%	1.10x	0.00x	Rs-1.34 Billion
2022	-651.37%	-148.19%	0.49x	8.97x	Rs-2.07 Billion
2023	-43.41%	-93.22%	0.29x	1.62x	Rs-2.74 Billion
2024	-307.91%	-512.56%	0.15x	4.10x	Rs-4.00 Billion
2025	0.00%	-477.23%	0.21x	0.00x	Rs-3.21 Billion

Industry Comparison

This section compares Sun Pharma Advanced Research Company Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $23,713,303,062
Average return on equity (ROE) among peers: 8.81%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Sun Pharma Advanced Research Company Limited (SPARC)	Rs-3.45 Billion	-10.03%	N/A	$502.01 Million
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)	$988.60 Million	6.59%	1.36x	$27.93 Million
Aarti Drugs Limited (AARTIDRUGS)	$6.52 Billion	21.67%	1.42x	$371.43 Million
Aarti Pharmalabs Limited (AARTIPHARM)	$19.90 Billion	13.69%	0.46x	$725.68 Million
Abbott India Limited (ABBOTINDIA)	$36.99 Billion	32.48%	0.40x	$5.85 Billion
Ajanta Pharma Limited (AJANTPHARM)	$1.16 Billion	12.69%	1.32x	$3.81 Billion
Akums Drugs and Pharmaceutical (AKUMS)	$6.25 Billion	-40.39%	3.91x	$906.19 Million
Alkem Laboratories Limited (ALKEM)	$88.47 Billion	18.60%	0.59x	$6.98 Billion
Amrutanjan Health Care Limited (AMRUTANJAN)	$1.46 Billion	16.82%	0.29x	$178.52 Million
Alembic Pharmaceuticals Limited (APLLTD)	$51.90 Billion	11.24%	0.50x	$1.60 Billion
Aurobindo Pharma Limited (AUROPHARMA)	$23.50 Billion	-5.26%	1.65x	$8.73 Billion

About Sun Pharma Advanced Research Company Limited

NSE:SPARC India Drug Manufacturers - Specialty & Generic

Market Cap

$502.01 Million

Rs46.42 Billion INR

Market Cap Rank

#12516 Global

#593 in India

Share Price

Rs143.04

Change (1 day)

-3.72%

52-Week Range

Rs108.71 - Rs198.54

All Time High

Rs519.35